Aryl hydrocarbon receptor and liver fibrosis

Zoubek, 2017, Reversal of liver fibrosis: from fiction to reality, Best Pract Res Clin Gastroenterol, 31, 129, 10.1016/j.bpg.2017.04.005 Joshi-Barve, 2015, Alcoholic, nonalcoholic, and toxicant-associated steatohepatitis: mechanistic similarities and differences, Cell Mol Gastroenterol Hepatol, 1, 356, 10.1016/j.jcmgh.2015.05.006 Guyot, 2013, The AhR twist: ligand-dependent AhR signaling and pharmaco-toxicological implications, Drug Discov Today, 18, 479, 10.1016/j.drudis.2012.11.014 Diry, 2006, Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism, Oncogene, 25, 5570, 10.1038/sj.onc.1209553 Bui, 2016, Regulation of Aquaporin 3 expression by the AhR pathway is critical to cell migration, Toxicol Sci, 149, 158, 10.1093/toxsci/kfv221 Tomkiewicz, 2013, The aryl hydrocarbon receptor regulates focal adhesion sites through a non-genomic FAK/Src pathway, Oncogene, 32, 1811, 10.1038/onc.2012.197 Yi, 2014, Agent Orange exposure and disease prevalence in Korean Vietnam veterans: the Korean veterans health study, Environ Res, 133, 56, 10.1016/j.envres.2014.04.027 Yi, 2014, Agent Orange exposure and risk of death in Korean Vietnam veterans: Korean veterans health study, Int J Epidemiol, 43, 1825, 10.1093/ije/dyu183 Michalek, 1998, Postservice mortality of US Air Force veterans occupationally exposed to herbicides in Vietnam: 15-year follow-up, Am J Epidemiol, 148, 786, 10.1093/oxfordjournals.aje.a009699 Ramlow, 1996, Mortality in a cohort of pentachlorophenol manufacturing workers, 1940–1989, Am J Ind Med, 30, 180, 10.1002/(SICI)1097-0274(199608)30:2<180::AID-AJIM9>3.0.CO;2-4 Pazderova-Vejlupková, 1981, The development and prognosis of chronic intoxication by tetrachlorodibenzo-p-dioxin in men, Arch Environ Health, 36, 5, 10.1080/00039896.1981.10667598 Ott, 1987, Cohort mortality study of chemical workers with potential exposure to the higher chlorinated dioxins, J Occup Med Off Publ Ind Med Assoc, 29, 422 Kimbrough, 1977, Epidemiology and pathology of a tetrachlorodibenzodioxin poisoning episode, Arch Environ Health, 32, 77, 10.1080/00039896.1977.10667259 Duval, 2017, Chronic exposure to low doses of dioxin promotes liver fibrosis development in the C57BL/6J diet-induced obesity mouse model, Environ Health Perspect, 125, 428, 10.1289/EHP316 Pierre, 2014, Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin, Toxicol Sci Off J Soc Toxicol, 137, 114, 10.1093/toxsci/kft236 He, 2013, Activation of the aryl hydrocarbon receptor sensitizes mice to nonalcoholic steatohepatitis by deactivating mitochondrial sirtuin deacetylase Sirt3, Mol Cell Biol, 33, 2047, 10.1128/MCB.01658-12 National Toxicology Program, 2006, NTP toxicology and carcinogenesis studies of 3,3′,4,4′,5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan sprague-dawley rats (gavage studies), Natl Toxicol Program Tech Rep Ser, 4 National Toxicology Program, 2006, NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies), Natl Toxicol Program Tech Rep Ser, 4 National Toxicology Program, 2006, Toxicology and carcinogenesis studies of a binary mixture of 3,3′,4,4′,5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies), Natl Toxicol Program Tech Rep Ser, 1 National toxicology program, 2006, Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan sprague-dawley rats (gavage studies), Natl Toxicol Program Tech Rep Ser, 1 National toxicology program, 2006, Natl Toxicol Program Tech Rep Ser, 1 National Toxicology Program, 2006, Toxicology and carcinogenesis studies of a binary mixture of 3,3′,4,4′,5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3′,4,4′,5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies), Natl Toxicol Program Tech Rep Ser, 1 Morel, 1999, Repression of gene expression by oxidative stress, Biochem J, 342, 481, 10.1042/bj3420481 Nault, 2016, Pyruvate kinase isoform switching and hepatic metabolic reprogramming by the environmental contaminant 2,3,7,8-Tetrachlorodibenzo-p-Dioxin, Toxicol Sci Off J Soc Toxicol, 149, 358, 10.1093/toxsci/kfv245 Zhang, 2012, Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases, Hepatol Balt Md, 55, 1840, 10.1002/hep.25566 Fader, 2017, Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity, Toxicol Appl Pharmacol, 321, 1, 10.1016/j.taap.2017.02.006 Lu, 2011, Nrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitis, Toxicol Appl Pharmacol, 256, 122, 10.1016/j.taap.2011.07.019 Harvey, 2016, Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increases human hepatic stellate cell activation, Toxicology, 344–346, 26, 10.1016/j.tox.2016.02.001 Han, 2017, 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces hepatic stellate cell (HSC) activation and liver fibrosis in C57BL6 mouse via activating Akt and NF-κB signaling pathways, Toxicol Lett, 273, 10, 10.1016/j.toxlet.2017.03.013 Lamb, 2016, 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases necroinflammation and hepatic stellate cell activation but does not exacerbate experimental liver fibrosis in mice, Toxicol Appl Pharmacol, 311, 42, 10.1016/j.taap.2016.09.025 Nault, 2017, Lipidomic evaluation of aryl hydrocarbon receptor-mediated hepatic steatosis in male and female mice elicited by 2,3,7,8-Tetrachlorodibenzo-p-dioxin, Chem Res Toxicol, 30, 1060, 10.1021/acs.chemrestox.6b00430 Angrish, 2012, Dietary fat is a lipid source in 2,3,7,8-Tetrachlorodibenzo-ρ-Dioxin (TCDD)-Elicited hepatic steatosis in C57BL/6 mice, Toxicol Sci, 128, 377, 10.1093/toxsci/kfs155 Mota, 2016, Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease, Metabolism, 65, 1049, 10.1016/j.metabol.2016.02.014 Bui, 2009, Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity, Oncogene, 28, 3642, 10.1038/onc.2009.224 Corchero, 2004, Liver portal fibrosis in dioxin receptor-null mice that overexpress the latent transforming growth factor-beta-binding protein-1, Int J Exp Pathol, 85, 295, 10.1111/j.0959-9673.2004.00397.x Lamb, 2016, Aryl hydrocarbon receptor activation by TCDD modulates expression of extracellular matrix remodeling genes during experimental liver fibrosis, BioMed Res Int, 2016, 10.1155/2016/5309328 Nault, 2016, From the cover: coagulation-driven hepatic fibrosis requires protease activated receptor-1 (PAR-1) in a mouse model of TCDD-elicited steatohepatitis, Toxicol Sci Off J Soc Toxicol, 154, 381, 10.1093/toxsci/kfw175 Kim, 2010, Fate and complex pathogenic effects of dioxins and polychlorinated biphenyls in obese subjects before and after drastic weight loss, Environ Health Perspect, 119, 377, 10.1289/ehp.1002848 Fernandez-Salguero, 1995, Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor, Science, 268, 722, 10.1126/science.7732381 Fernandez-Salguero, 1997, Lesions of aryl-hydrocarbon receptor-deficient mice, Vet Pathol, 34, 605, 10.1177/030098589703400609 Schmidt, 1996, Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development, Proc Natl Acad Sci USA, 93, 6731, 10.1073/pnas.93.13.6731 Zaher, 1998, The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis, Mol Pharmacol, 54, 313, 10.1124/mol.54.2.313 Andreola, 1997, Aryl hydrocarbon receptor knockout mice (AHR−/−) exhibit liver retinoid accumulation and reduced retinoic acid metabolism, Cancer Res, 57, 2835 Andreola, 2004, Reversal of liver fibrosis in aryl hydrocarbon receptor null mice by dietary vitamin A depletion, Hepatol Balt Md, 39, 157, 10.1002/hep.20004 Andreola, 2004, Mouse liver CYP2C39 is a novel retinoic acid 4-hydroxylase. Its down-regulation offers a molecular basis for liver retinoid accumulation and fibrosis in aryl hydrocarbon receptor-null mice, J Biol Chem, 279, 3434, 10.1074/jbc.M305832200 Floreani, 2013, Severe liver cirrhosis markedly reduces AhR-mediated induction of cytochrome P450 in rats by decreasing the transcription of target genes, PloS One, 8, 10.1371/journal.pone.0061983 Hanada, 2012, Effect of nuclear receptor downregulation on hepatic expression of cytochrome P450 and transporters in chronic hepatitis C in association with fibrosis development, Drug Metab Pharmacokinet, 27, 301, 10.2133/dmpk.DMPK-11-RG-077 Sartor, 2009, Genomewide analysis of aryl hydrocarbon receptor binding targets reveals an extensive array of gene clusters that control morphogenetic and developmental programs, Environ Health Perspect, 117, 1139, 10.1289/ehp.0800485 Yao, 2016, Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice, Hepatol Balt Md, 64, 92, 10.1002/hep.28518 Ganeshan, 2017, Warming the mouse to model human diseases, Nat Rev Endocrinol, 13, 458, 10.1038/nrendo.2017.48 Attignon, 2017, Novel roles for AhR and ARNT in the regulation of alcohol dehydrogenases in human hepatic cells, Arch Toxicol, 91, 313, 10.1007/s00204-016-1700-4 Nault, 2015, Development of a computational high-throughput tool for the quantitative examination of dose-dependent histological features, Toxicol Pathol, 43, 366, 10.1177/0192623314544379 Liu, 2014, Histopathologic alterations associated with global gene expression due to chronic dietary TCDD exposure in juvenile zebrafish, PloS One, 9